ARCpoint Inc. (TSXV:ARC)

Canada flag Canada · Delayed Price · Currency is CAD
0.0100
0.00 (0.00%)
May 1, 2026, 10:53 AM EST
Market Cap1.28M -88.0%
Revenue (ttm)830.50K -89.0%
Net Income-2.90M
EPS-0.03
Shares Out128.36M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume52,980
Open0.0100
Previous Close0.0100
Day's Range0.0100 - 0.0100
52-Week Range0.0050 - 0.0800
Beta-2.04
RSI45.83
Earnings DateMay 1, 2026

About ARCpoint

ARCpoint Inc. provides franchise systems offering drug, alcohol, DNA, and clinical lab testing and screening services in the United States. It operates in two segments, ARCpoint Franchise and AFG Services. The company offers viral testing for viruses, such as Flu, Strep, and covid; regulatory compliance testing; ailments testing; preventive care services, including annual health, heart health, thyroid, diabetes, and hormone testing; nutritional testing comprising food allergy/sensitivity and vitamin/nutrient deficiency testing; and specialty he... [Read more]

Sector Healthcare
Founded 1998
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol ARC
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

ARCpoint Earnings Call Transcript: Q3 2024

Q3 2024 saw a major joint venture with Creso Brands, expanding reach to over 370 locations and driving a $6.3M accounting gain. Revenue declined due to deconsolidation, but net income and EBITDA improved significantly. 2025 is expected to bring further growth as platform adoption increases.

1 year ago - Transcripts